[Use of a lung function screening device for identifying patients at risk for COPD in general practice].

PubWeight™: 2.01‹?› | Rank: Top 2%

🔗 View Article (PMID 23132318)

Published in Pneumologie on November 06, 2012

Authors

M Müller1, H Kögler, T Glaab, T Welte

Author Affiliations

1: Pfizer, Med. Wissenschaft, Berlin.

Articles by these authors

(truncated to the top 100)

Weaning from mechanical ventilation. Eur Respir J (2007) 3.59

New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality. Thorax (2009) 3.21

Preparedness for admission of patients with suspected Ebola virus disease in European hospitals: a survey, August-September 2014. Euro Surveill (2014) 2.65

ErbB4 signaling in the mammary gland is required for lobuloalveolar development and Stat5 activation during lactation. J Cell Biol (1999) 2.03

Combination therapy with bosentan and sildenafil in idiopathic pulmonary arterial hypertension. Eur Respir J (2004) 2.02

Outcome of community-acquired pneumonia: influence of age, residence status and antimicrobial treatment. Eur Respir J (2008) 1.97

Randomized phase II study of cetuximab plus cisplatin/vinorelbine compared with cisplatin/vinorelbine alone as first-line therapy in EGFR-expressing advanced non-small-cell lung cancer. Ann Oncol (2007) 1.90

Extracorporeal membrane oxygenation in nonintubated patients as bridge to lung transplantation. Am J Transplant (2010) 1.87

Cathepsin K--a marker of macrophage differentiation? J Pathol (2001) 1.77

Experience with inhaled iloprost and bosentan in portopulmonary hypertension. Eur Respir J (2007) 1.75

Goal-oriented treatment and combination therapy for pulmonary arterial hypertension. Eur Respir J (2005) 1.71

Transgenic mouse model of stunned myocardium. Science (2000) 1.62

CRB-65 predicts death from community-acquired pneumonia. J Intern Med (2006) 1.61

[Guidelines for diagnosis and treatment of asthma patients]. Pneumologie (2006) 1.59

Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory. Clin Infect Dis (2008) 1.55

Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: Diagnosis, incidence and predictors. Eur Respir J (2009) 1.54

[Management of a new influenza A/H1N1 virus pandemic within the hospital: statement of the German Society of Pneumology]. Pneumologie (2009) 1.51

Phenotyping established chronic lung allograft dysfunction predicts extracorporeal photopheresis response in lung transplant patients. Am J Transplant (2013) 1.49

Cathepsin-regulated apoptosis. Apoptosis (2006) 1.47

[Pneumococcal vaccination: conjugated vaccine induces herd immunity and reduces antibiotic resistance]. Dtsch Med Wochenschr (2008) 1.45

Drug-drug interactions in medical patients: effects of in-hospital treatment and relation to multiple drug use. Int J Clin Pharmacol Ther (2000) 1.44

Severe acute respiratory syndrome: global initiatives for disease diagnosis. QJM (2003) 1.44

Vasorelaxant effect of glucagon-like peptide-(7-36)amide and amylin on the pulmonary circulation of the rat. Regul Pept (2001) 1.42

Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection. Eur Respir J (2010) 1.38

Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes. Eur Respir J (2007) 1.34

Stat1 as a component of tumor necrosis factor alpha receptor 1-TRADD signaling complex to inhibit NF-kappaB activation. Mol Cell Biol (2000) 1.33

The prognostic impact of follow-up assessments in patients with idiopathic pulmonary arterial hypertension. Eur Respir J (2011) 1.28

Development and validation of the Capacity of Daily Living during the Morning questionnaire and the Global Chest Symptoms Questionnaire in COPD. Eur Respir J (2009) 1.24

[Guidelines for the diagnosis and therapy of COPD issued by Deutsche Atemwegsliga and Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin]. Pneumologie (2007) 1.23

[Epidemiology, diagnosis and treatment of adult patients with nosocomial pneumonia. S-3 Guideline of the German Society for Anaesthesiology and Intensive Care Medicine, the German Society for Infectious Diseases, the German Society for Hygiene and Microbiology, the German Respiratory Society and the Paul-Ehrlich-Society for Chemotherapy]. Pneumologie (2012) 1.23

The aetiology and antibiotic management of community-acquired pneumonia in adults in Europe: a literature review. Eur J Clin Microbiol Infect Dis (2014) 1.22

Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma. Curr Med Res Opin (2004) 1.21

The use of noninvasive pressure support ventilation for severe respiratory insufficiency due to pulmonary oedema. Intensive Care Med (1999) 1.21

Development and evaluation of an implementation strategy for the German guideline on community-acquired pneumonia. Qual Saf Health Care (2010) 1.16

Bridge to thoracic organ transplantation in patients with pulmonary arterial hypertension using a pumpless lung assist device. Am J Transplant (2009) 1.15

[Epidemiology, diagnosis, antimicrobial therapy and management of community-acquired pneumonia and lower respiratory tract infections in adults. Guidelines of the Paul-Ehrlich-Society for Chemotherapy, the German Respiratory Society, the German Society for Infectiology and the Competence Network CAPNETZ Germany]. Pneumologie (2009) 1.15

Effects of propofol and desflurane anaesthesia on the alveolar inflammatory response to one-lung ventilation. Br J Anaesth (2007) 1.13

Prevention, diagnosis, therapy and follow-up care of sepsis: 1st revision of S-2k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V. (DSG)) and the German Interdisciplinary Association of Intensive Care and Emergency Medicine (Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin (DIVI)). Ger Med Sci (2010) 1.13

Suppression of pulmonary innate host defence in smokers. Thorax (2008) 1.12

Gemcitabine, vinorelbine and cisplatin combination chemotherapy in advanced non-small cell lung cancer: a phase II trial. Eur J Cancer (2002) 1.11

The burden of pneumococcal pneumonia - experience of the German competence network CAPNETZ. Pneumologie (2012) 1.10

[SARS--Severe Acute Respiratory syndrome]. Pneumologie (2003) 1.09

Assisted ventilation for heart failure patients with Cheyne-Stokes respiration. Eur Respir J (2002) 1.08

[The prevalence of chronic obstructive pulmonary disease (COPD) in Germany. Results of the BOLD study]. Dtsch Med Wochenschr (2008) 1.08

Are metallic stents really safe? A long-term analysis in lung transplant recipients. Eur Respir J (2009) 1.06

Expression of cathepsin K in lung epithelial cells. Am J Respir Cell Mol Biol (1999) 1.04

Promoter-dependent synergy between glucocorticoid receptor and Stat5 in the activation of beta-casein gene transcription. J Biol Chem (1997) 1.04

Mesalazine alveolitis. Lancet (1991) 1.02

Circulating complement proteins in patients with sepsis or systemic inflammatory response syndrome. Clin Diagn Lab Immunol (1996) 1.01

An observational real-time study to analyze junior physicians' working hours in the field of gastroenterology. Z Gastroenterol (2009) 1.00

Sequential development of airway hyperresponsiveness and acute airway obstruction in a mouse model of allergic inflammation. Int Arch Allergy Immunol (2000) 0.99

Dominance of IL-12 over IL-4 in gamma delta T cell differentiation leads to default production of IFN-gamma: failure to down-regulate IL-12 receptor beta 2-chain expression. J Immunol (2000) 0.98

CCAAT/enhancer-binding protein isoforms beta and delta are expressed in mammary epithelial cells and bind to multiple sites in the beta-casein gene promoter. J Biol Chem (1995) 0.97

[S3-guideline on ambulant acquired pneumonia and deep airway infections]. Pneumologie (2005) 0.97

[Prevention, diagnosis, treatment, and follow-up care of sepsis. First revision of the S2k Guidelines of the German Sepsis Society (DSG) and the German Interdisciplinary Association for Intensive and Emergency Care Medicine (DIVI)]. Anaesthesist (2010) 0.96

Interleukin-6 and transforming growth factor-beta 1 control expression of cathepsins B and L in human lung epithelial cells. J Interferon Cytokine Res (2001) 0.96

A distal enhancer region in the human beta-casein gene mediates the response to prolactin and glucocorticoid hormones. Gene (1998) 0.95

Randomized phase III study of gemcitabine and vinorelbine versus gemcitabine, vinorelbine, and cisplatin in the treatment of advanced non-small-cell lung cancer: from the German and Swiss Lung Cancer Study Group. J Clin Oncol (2004) 0.95

European perspective and update on the management of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid. Clin Microbiol Infect (2014) 0.94

Impact of graft colonization with gram-negative bacteria after lung transplantation on the development of bronchiolitis obliterans syndrome in recipients with cystic fibrosis. Respir Med (2008) 0.94

Alternative mechanisms for tiotropium. Pulm Pharmacol Ther (2009) 0.94

Localization of TFF3, a new mucus-associated peptide of the human respiratory tract. Am J Respir Crit Care Med (1999) 0.94

Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) pneumonia: linezolid or vancomycin? - Comparison of pharmacology and clinical efficacy. Eur J Med Res (2010) 0.94

Central sleep apnoea syndrome in patients with chronic heart disease: a critical review of the current literature. Thorax (2002) 0.93

Pneumococcal vaccination: what have we learnt so far and what can we expect in the future? Eur J Clin Microbiol Infect Dis (2014) 0.93

Experience with pneumococcal polysaccharide conjugate vaccine (conjugated to CRM197 carrier protein) in children and adults. Clin Microbiol Infect (2013) 0.93

Predicting outcome and survival in patients with Wegener's granulomatosis treated on the intensive care unit. Scand J Rheumatol (2007) 0.92

A mouse model of myocardial stunning. Mol Med Today (2000) 0.92

Prognostic value of blood gas analyses in patients with idiopathic pulmonary arterial hypertension. Eur Respir J (2007) 0.92

Comparison of three-dimensional virtual endoscopy with bronchoscopy in patients with oesophageal carcinoma infiltrating the tracheobronchial tree. Br J Radiol (1998) 0.92

Risk factors for community-acquired pneumonia in German adults: the impact of children in the household. Epidemiol Infect (2007) 0.92

Cathepsin K expression in human lung. Adv Exp Med Biol (2000) 0.92

[Systemic manifestations and comorbidities in patients with chronic obstructive pulmonary disease (COPD) and their effect on clinical state and course of the disease--an overview of the cohort study COSYCONET]. Dtsch Med Wochenschr (2010) 0.91

Cough as a symptom and a disease entity: scientometric analysis and density-equalizing calculations. J Investig Allergol Clin Immunol (2009) 0.91

[Health effects of particulate matter exposure: current scientific knowledge]. Pneumologie (2009) 0.91

[The German centre for lung research - translational research for the prevention, diagnosis and treatment of respiratory diseases]. Pneumologie (2012) 0.91

Diagnostic potential of virtual bronchoscopy: advantages in comparison with axial CT slices, MPR and mIP? Eur Radiol (2000) 0.90

Impact of intravenous {beta}-lactam/macrolide versus {beta}-lactam monotherapy on mortality in hospitalized patients with community-acquired pneumonia. J Antimicrob Chemother (2009) 0.90

Predicting mortality in hospitalized patients with 2009 H1N1 influenza pneumonia. Int J Tuberc Lung Dis (2011) 0.90

[Guidelines for the diagnosis and treatment chronic obstructive bronchitis and pulmonary emphysema issued by Deutsche Atemwegsliga and Deutsche Gesellschaft für pneumologie]. Pneumologie (2002) 0.90

Piperacillin/tazobactam vs imipenem/cilastatin in the treatment of nosocomial pneumonia--a double blind prospective multicentre study. Infection (2006) 0.89

Enhanced cost-benefit analysis of strategies for LTBI screening and INH chemoprevention in Germany. Respir Med (2009) 0.89

Comparative study on the phosphotyrosine motifs of different cytokine receptors involved in STAT5 activation. FEBS Lett (1996) 0.89

Evidence of a defective thiol status of alveolar macrophages from COPD patients and smokers. Chronic obstructive pulmonary disease. Free Radic Biol Med (2000) 0.89

Influenza vaccination is associated with reduced severity of community-acquired pneumonia. Eur Respir J (2010) 0.89

Mechanism of interaction between the glucocorticoid receptor and Stat5: role of DNA-binding. Immunobiology (1997) 0.89

[Diagnosis and therapy of sepsis]. Clin Res Cardiol (2006) 0.87

Increased release of transforming growth factor (TGF)-beta1, TGF-beta2, and chemoattractant mediators in pneumonia. J Interferon Cytokine Res (1999) 0.87

Pituitary adenylate cyclase-activating peptide receptor 1 mediates anti-inflammatory effects in allergic airway inflammation in mice. Clin Exp Allergy (2010) 0.87

Lysosomal cysteine proteases in the lung: role in protein processing and immunoregulation. Eur Respir J (2004) 0.86

Treatment failure in pneumonia: impact of antibiotic treatment and cost analysis. Eur Respir J (2011) 0.86

Expression of cathepsins B, H, K, L, and S during human fetal lung development. Dev Dyn (2002) 0.86

[Diagnosis and therapy of sepsis: guidelines of the German Sepsis Society Inc. and the German Interdisciplinary Society for Intensive and Emergency Medicine]. Anaesthesist (2006) 0.86

[Epidemiology and Aetiology of Community-acquired Pneumonia (CAP)]. Dtsch Med Wochenschr (2011) 0.85

The Src-protein tyrosine kinase Lck is required for IL-1-mediated costimulatory signaling in Th2 cells. J Immunol (2001) 0.85

Surfactant protein D inhibits early airway response in Aspergillus fumigatus-sensitized mice. Clin Exp Allergy (2006) 0.85

Selective coupling of STAT factors to the mouse prolactin receptor. Eur J Biochem (1998) 0.85

Reduced airway inflammation in CD26/DPP4-deficient F344 rats is associated with altered recruitment patterns of regulatory T cells and expression of pulmonary surfactant proteins. Clin Exp Allergy (2010) 0.85

MRP8/MRP14, CD11b and HLA-DR expression of alveolar macrophages in pneumonia. Immunol Lett (2000) 0.84

Treatment strategies for Cheyne-Stokes respiration. Eur Respir J (2006) 0.84